Issue 3, 2024
From the journal:

Natural Product Reports

Correction: Future antimalarials from Artemisia? A rationale for natural product mining against drug-refractory Plasmodium stages

Alexandre Maciuk,a   Dominique Mazierb  and  Romain Duval*c  

* Corresponding authors

a BioCIS, CNRS, Université Paris-Saclay, 91400 Orsay, France

b CIMI, CNRS, Inserm, Faculté de Médecine Sorbonne Université, 75013 Paris, France

c MERIT, IRD, Université Paris Cité, 75006 Paris, France
E-mail: romain.duval@ird.fr
Fax: +33-1-5373-9617
Tel: +33-1-5373-9933

Abstract

Correction for ‘Future antimalarials from Artemisia? A rationale for natural product mining against drug-refractory Plasmodium stages’ by Alexandre Maciuk et al., Nat. Prod. Rep., 2023, 40, 1130–1144, https://doi.org/10.1039/D3NP00001J.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D4NP90001D
Article type
Correction
Submitted
05 Jan 2024
Accepted
05 Jan 2024
First published
17 Jan 2024
This article is Open Access
Creative Commons BY license

Nat. Prod. Rep., 2024,41, 512-512

Permissions

Request permissions

Correction: Future antimalarials from Artemisia? A rationale for natural product mining against drug-refractory Plasmodium stages

A. Maciuk, D. Mazier and R. Duval, Nat. Prod. Rep., 2024, 41, 512 DOI: 10.1039/D4NP90001D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements